Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
Clinical trial NCT02706652 · TERMINATED
Trial details
- NCT number
- NCT02706652
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2018-05-22
- Primary completion
- 2019-09-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.